Academic Research Organization, Hospital Israelita Albert Einstein, Av. Albert Einstein 627, Bloco A, 2o subsolo, São Paulo, SP, CEP 05652-900, Brazil.
Westmead Applied Research Centre, Westmead Clinical School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
Curr Atheroscler Rep. 2020 Oct 3;22(12):71. doi: 10.1007/s11883-020-00889-x.
To review the current evidence supporting the use of digital health technologies in cardiovascular disease (CVD) care.
Studies have evaluated the impact of the use of digital health technologies to improve CVD outcomes through several modalities: text-messaging programmes, smartphone applications (apps) and wearable devices. Text-messaging programmes are to date the most studied type of digital health interventions, and studies have demonstrated reduced CVD risk and improved medication adherence. Literature supporting the use of smartphone apps is also growing but remains limited, with some studies favouring the use of health apps but others showing negative results. Wearable devices are the latest type of technology investigated, and studies have shown positive outcomes in terms of physical activity and detection of arrhythmias. Digital health is a growing and evolving area of investigation. To date, the scientific evidence overall supports the use of such technologies in CVD care and management. Future research using new models are needed to continue to evaluate these new technologies.
回顾当前支持将数字健康技术应用于心血管疾病 (CVD) 治疗的证据。
多项研究评估了使用数字健康技术通过以下几种方式改善 CVD 结局的效果：短信计划、智能手机应用程序 (apps) 和可穿戴设备。短信计划是迄今为止研究最多的数字健康干预类型，研究表明可降低 CVD 风险和提高药物依从性。支持使用智能手机应用程序的文献也在不断增加，但仍然有限，一些研究赞成使用健康应用程序，但其他研究结果则为负面。可穿戴设备是最新研究的技术类型，研究表明在身体活动和心律失常检测方面有积极的结果。数字健康是一个不断发展和演变的研究领域。迄今为止，总体而言，科学证据支持在 CVD 护理和管理中使用这些技术。需要使用新模型的未来研究来继续评估这些新技术。
